Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
A chemical biology laboratory at the Dana-Farber Cancer Institute is seeking a highly-motivated post-doctoral fellow who will contribute to drug-discovery projects focused on deubiquitinating enzymes (DUBs). The ideal candidate will have previous experience in biochemistry and cell biology.
Responsibilities will include biochemical and cell-based experiments to investigate the basic function and disease relevance of DUB enzymes. The successful candidate will work with an interdisciplinary team including medicinal chemists, structural biologists, and cancer biologists to discover and develop chemical probes, and unravel the function of DUB targets.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.
Ph.D. Degree with experience in biochemistry and/or cell biology